Training activity information
Details
Perform vertical audit of a sample analysed for a ‘toxicology screen’
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Considerations
- Sample receipt, sample quality, timeliness, analysis, reporting, and retesting,
- Standard, guideline or consensus document for audit against
- Principles of audit and the audit cycle.
- Quality control; EQA and IQC
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 1 |
Outcome
Analyse drugs, vitamins and trace elements in various biological matrices via quantitative and qualitative assays using automated and manual methodologies. |
| # 2 |
Outcome
Apply the appropriate investigative strategy to clinical situations which may involve drugs or poisons, advising clinical teams on the appropriate course of action. |
| # 3 |
Outcome
Appraise the methods in routine use for ‘drugs of abuse’ screening and advise on the interpretation of common analytes. |
| # 4 |
Outcome
Summarise the limitations of comprehensive toxicology screening in clinical practice. |
| # 5 |
Outcome
Demonstrate the application of pharmacokinetics and pharmacogenomics in therapeutic drug monitoring. |
| # 6 |
Outcome
Illustrate how toxicology results are used in clinical practice and the legal consequences of drug testing in various settings. |